SUSAN SAILER: Open Payments
NPI 1720161490 · WYNNEWOOD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$723 in 32 payments from 19 companies in 2025. Trend: 2023 $1,252 · 2024 $2,605 · 2025 $723
Food & beverage: $723
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $110 |
| Astellas Pharma US Inc | 4 | $83 |
| ABBVIE INC. | 3 | $66 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| TOLMAR, INC. | 2 | $44 |
| COLOPLAST CORP | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $29 |
Products named: ERLEADA, Xtandi, PLUVICTO, BOTOX, Luja Coude, Nubeqa, LYNPARZA, PYLARIFY.
Industry payments across PA — which companies pay providers there.
